A K Burroughs

4.7k total citations
43 papers, 1.3k citations indexed

About

A K Burroughs is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, A K Burroughs has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 23 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in A K Burroughs's work include Liver Disease and Transplantation (23 papers), Liver Disease Diagnosis and Treatment (21 papers) and Organ Transplantation Techniques and Outcomes (8 papers). A K Burroughs is often cited by papers focused on Liver Disease and Transplantation (23 papers), Liver Disease Diagnosis and Treatment (21 papers) and Organ Transplantation Techniques and Outcomes (8 papers). A K Burroughs collaborates with scholars based in United Kingdom, Italy and United States. A K Burroughs's co-authors include P. Aiden McCormick, Marcello Vangeli, Neil McIntyre, Edward G. D. Tuddenham, Andrea Mancuso, Maria Mela, Keith Rolles, R. Stigliano, Vincenza Calvaruso and Anne Riddell and has published in prestigious journals such as Hepatology, Gut and The Journal of Infectious Diseases.

In The Last Decade

A K Burroughs

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A K Burroughs United Kingdom 24 905 787 479 119 98 43 1.3k
Isabelle Morard Switzerland 17 1.1k 1.2× 825 1.0× 730 1.5× 152 1.3× 51 0.5× 35 1.6k
Neil Fisher United Kingdom 14 515 0.6× 409 0.5× 434 0.9× 184 1.5× 100 1.0× 29 1.2k
AK Burroughs United Kingdom 22 1.6k 1.8× 1.5k 1.9× 819 1.7× 51 0.4× 50 0.5× 80 2.3k
A. Balzano Italy 23 1.3k 1.5× 1.1k 1.4× 1.1k 2.3× 45 0.4× 187 1.9× 48 2.4k
John Goulis Greece 21 1.8k 1.9× 1.7k 2.2× 700 1.5× 59 0.5× 66 0.7× 49 2.1k
Jau‐Min Lien Taiwan 16 752 0.8× 630 0.8× 323 0.7× 26 0.2× 65 0.7× 31 1.2k
Josep Terés Spain 18 1.7k 1.9× 1.5k 1.9× 945 2.0× 106 0.9× 33 0.3× 28 2.0k
Vasiliki Arvaniti United Kingdom 9 1.1k 1.3× 1.1k 1.3× 391 0.8× 48 0.4× 32 0.3× 9 1.4k
Federico Ravaioli Italy 26 990 1.1× 1.1k 1.5× 391 0.8× 59 0.5× 153 1.6× 80 1.9k
M. Cazzaniga Italy 18 1.9k 2.1× 1.7k 2.2× 866 1.8× 35 0.3× 94 1.0× 35 2.3k

Countries citing papers authored by A K Burroughs

Since Specialization
Citations

This map shows the geographic impact of A K Burroughs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A K Burroughs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A K Burroughs more than expected).

Fields of papers citing papers by A K Burroughs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A K Burroughs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A K Burroughs. The network helps show where A K Burroughs may publish in the future.

Co-authorship network of co-authors of A K Burroughs

This figure shows the co-authorship network connecting the top 25 collaborators of A K Burroughs. A scholar is included among the top collaborators of A K Burroughs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A K Burroughs. A K Burroughs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pericleous, Marinos, et al.. (2011). Hepatobiliary Disease Associated with Hypereosinophilia: A Report of Two Patients and a Review of the Literature. Digestive Diseases and Sciences. 56(12). 3689–3694. 1 indexed citations
2.
Violi, Francesco, Stefania Basili, Valeria Raparelli, et al.. (2011). Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?. Journal of Hepatology. 55(6). 1415–1427. 120 indexed citations
3.
Belli, L, Peter Stärkel, Riccardo Volpes, et al.. (2009). Peg-ifn-alfa 2b With Ribavirin for the Treatment of Mild-moderate Recurrent Hepatitis C After Liver Transplantation (lt) : Impact On Fibrosis Progression. a Multicenter Randomized Controlled Study. Hepatology. 50(4). 192–192. 1 indexed citations
4.
Cholongitas, Εvangelos & A K Burroughs. (2009). Liver Diseases Specific to Pregnancy. Annals of Gastroenterology. 21(3). 164–172. 2 indexed citations
5.
Senzolo, Marco, Εvangelos Cholongitas, Jonathan Tibballs, et al.. (2006). Relief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without the need for long-term stenting. Endoscopy. 38(7). 760–760. 9 indexed citations
6.
Stigliano, R. & A K Burroughs. (2005). Should we biopsy each liver mass suspicious for HCC before liver transplantation?–No, please don't. Journal of Hepatology. 43(4). 563–568. 49 indexed citations
7.
Mattes, Frank, Emma Hainsworth, Anna María Geretti, et al.. (2004). A Randomized, Controlled Trial Comparing Ganciclovir to Ganciclovir Plus Foscarnet (Each at Half Dose) for Preemptive Therapy of Cytomegalovirus Infection in Transplant Recipients. The Journal of Infectious Diseases. 189(8). 1355–1361. 73 indexed citations
8.
Burroughs, A K. (2002). Induction immunosuppression for patients who underwent transplantation for cirrhosis caused by hepatitis C? The answer is no!. Liver Transplantation. 8(10). s47–s49. 7 indexed citations
9.
Burroughs, A K. (2000). Posttransplantation prevention and treatment of recurrent hepatitis C. Liver Transplantation. 6(6). s35–s40. 23 indexed citations
10.
Papatheodoridis, George, et al.. (1999). Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma. Thrombosis and Haemostasis. 620–620. 1 indexed citations
11.
Ben‐Ari, Ziv, et al.. (1998). Infection rates with and without T-tube splintage of common bile duct anastomosis in liver transplantation. Transplant International. 11(2). 123–126. 30 indexed citations
12.
McCormick, P. Aiden, Lynda Greenslade, C Kibbler, et al.. (1997). A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients. Hepatology. 25(4). 833–836. 38 indexed citations
13.
Saada, Julien, S. Bhattacharya, A.P. Dhillon, et al.. (1997). Detection of small hepatocellular carcinomas in cirrhotic livers using iodised oil computed tomography. Gut. 41(3). 404–407. 26 indexed citations
14.
Fraser, Gerald, et al.. (1996). Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: A positive therapeutic aim. Liver Transplantation and Surgery. 2(6). 411–417. 32 indexed citations
15.
Burroughs, A K. (1992). Medical Management of Bleeding Esophageal Varices. Digestive Diseases. 10(1). 30–37. 5 indexed citations
16.
Sprengers, Dave, et al.. (1990). Bleeding time in patients with hepatic cirrhosis.. BMJ. 301(6742). 12–15. 45 indexed citations
17.
Burroughs, A K, et al.. (1990). Bleeding time in patients with hepatic cirrhosis.. BMJ. 301(6750). 494.1–495. 4 indexed citations
18.
McCormick, P. Aiden, Andrew J. Sawyer, Neil McIntyre, & A K Burroughs. (1989). Carcinoma of the Esophagus and Long-term Sclerotherapy. Endoscopy. 21(3). 152–152. 3 indexed citations
19.
Heaton, K W, A. P. Shepherd, Philip D. Ross, et al.. (1986). The British Society of Gastroenterology. Gut. 27(10). A1234–A1285. 2 indexed citations
20.
Burroughs, A K, et al.. (1985). Desmopressin and bleeding time in patients with cirrhosis.. BMJ. 291(6506). 1377–1381. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Morard Breakdown of academic impact, for papers by Neil Fisher Breakdown of academic impact, for papers by AK Burroughs Breakdown of academic impact, for papers by A. Balzano Breakdown of academic impact, for papers by John Goulis Breakdown of academic impact, for papers by Jau‐Min Lien Breakdown of academic impact, for papers by Josep Terés Breakdown of academic impact, for papers by Vasiliki Arvaniti Breakdown of academic impact, for papers by Federico Ravaioli Breakdown of academic impact, for papers by M. Cazzaniga
Rankless by CCL
2026